SEC Form 4 · accession 0001209191-17-014942
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Rubino
Officer — Chief Financial Officer
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 6:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2017 | A | 4,780 | $0.00 | A | 403,912 | D | |
| Common Stock | Feb 24, 2017 | F | 932 | $44.55 | D | 402,980 | D | |
| Common Stock | Feb 25, 2017 | F | 845 | $44.55 | D | 402,135 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $44.25 | Feb 23, 2017 | A | 43,019 | A | — | Feb 23, 2027 | Common Stock | 43,019 | 43,019 | D |
Explanation of responses
- F1These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 23, 2017.
- F2This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of February 23, 2017.